医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

VGLL fusions define a new class of intraparenchymal central nervous system schwannoma.

广告
第一作者: Simone,Schmid
第一单位: German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neuropathologie, Berlin, Germany.
作者单位: German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neuropathologie, Berlin, Germany. [1] Department of Pathology, University of California San Francisco, San Francisco, California, USA.;Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.;Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA. [2] Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neuroradioloie, Berlin, Germany. [3] Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neurology, Berlin, Germany. [4] Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neuropathologie, Berlin, Germany. [5] Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tübingen, Germany. [6] Hertie Institute for Clinical Brain Research, Tübingen, Germany.;Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center, Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls University Tübingen, Germany. [7] Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA.;Department of Pathology, NYU Grossman School of Medicine, New York, USA. [8] Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany. [9] Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology and Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK. [10] Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK.;Children's Brain Tumour Research Centre, University of Nottingham Biodiscovery Institute, Nottingham, UK. [11] Clinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumour Diseases (NCT), Heidelberg, Germany. [12] Institute of Neuropathology, University Hospital Münster, Münster, Germany. [13] Partner of the European Reference Network (ERN) EpiCARE, Barcelona, Spain.;Department of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany. [14] Neurooncology Disease Management Group, Tata Memorial Centre, Dr Ernest Borges Marg and Homi Bhabha National Institute, Mumbai, India. [15] Institute of Neuropathology, University Medical Center Goettingen, Goettingen, Germany. [16] Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for pLGG in children and adolescents, Department of Pediatric Oncology and Hematology, Berlin, Germany. [17] Department of Pathology, Akron Children's, Ohio, USA. [18] Department of Radiological, Oncological and Anatomic Pathology, Sapienza University, Rome, Italy.;Department of Laboratory Medicine and Pathobiology-Neuropathology, Hospital for Sick Children (SickKids), Toronto, Ontario, Canada. [19] Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. [20] Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. [21] Providence Hood River Memorial Hospital, Hood River, Oregon, USA.;Department of Pathology, The Dalles, Oregon, USA. [22] Department of Pathology, University of Utah, Salt Lake City, Utah, USA. [23] Laboratory of Pathology, National Cancer Institute, Centre for Cancer Research, Bethesda, Maryland, USA. [24] Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. [25] Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.;National Center for Tumor Diseases (NCT), Heidelberg, Germany.;Heidelberg Medical Faculty, University of Heidelberg, Heidelberg, Germany.;Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. [26] Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany. [27] Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Oncology and Hematology, Berlin, Germany.;German HIT-LOGGIC-Registry of low-grade glioma in children and adolescents. [28] Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.;Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. [29] Department of Pathology, University of California San Francisco, San Francisco, California, USA.;Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA. [30] Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany. [31] German Cancer Research Center (DKFZ), Heidelberg, Germany.;Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.;National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Germany. [32] German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany. [33]
DOI 10.1093/neuonc/noae269
PMID 39713960
发布时间 2025-12-24
基金项目
提交
  • 浏览0
Neuro-oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷